Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-26-049427
Filing Date
2026-04-27
Accepted
2026-04-27 16:05:20
Documents
20
Period of Report
2026-06-17

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm261513-1_def14a.htm   iXBRL DEF 14A 604578
4 GRAPHIC ic_internet-bw.jpg GRAPHIC 4907
5 GRAPHIC ic_mail-bw.jpg GRAPHIC 4093
6 GRAPHIC ic_meeting-bw.jpg GRAPHIC 3962
7 GRAPHIC ic_phone-bw.jpg GRAPHIC 4579
8 GRAPHIC ic_tick-bw.jpg GRAPHIC 1820
9 GRAPHIC lg_cognition-4c.jpg GRAPHIC 14880
10 GRAPHIC px_26cognitproxy1pg01-bw.jpg GRAPHIC 219973
11 GRAPHIC px_26cognitproxy1pg02-bw.jpg GRAPHIC 147389
  Complete submission text file 0001104659-26-049427.txt   1879454

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cgtx-20251231.xsd EX-101.SCH 6628
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cgtx-20251231_lab.xml EX-101.LAB 22790
23 EXTRACTED XBRL INSTANCE DOCUMENT tm261513-1_def14a_htm.xml XML 4616
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2500 WESTCHESTER AVE PURCHASE NY 10577 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40886 | Film No.: 26900848
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)